Sandoz Launches High-Concentration Adalimumab In Europe
Plans To ‘Progressively’ Roll Out 100mg/ml Version Of Hyrimoz Biosimilar To Humira
• By David Wallace
Sandoz will be offering a 100mg/ml high-concentration formulation of Hyrimoz alongside the existing 50mg/ml low-concentration version • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
